Unique ID issued by UMIN | UMIN000022341 |
---|---|
Receipt number | R000025457 |
Scientific Title | A Multicenter, single-blind, randomized, parallel-group trial comparing Reinforced Reload with Tri-Staple with Tri-Staple during Distal Pancreatectomy |
Date of disclosure of the study information | 2016/05/18 |
Last modified on | 2019/02/05 18:01:36 |
A Multicenter, single-blind, randomized, parallel-group trial comparing Reinforced Reload with Tri-Staple with Tri-Staple during Distal Pancreatectomy
RETTS-DP trial
A Multicenter, single-blind, randomized, parallel-group trial comparing Reinforced Reload with Tri-Staple with Tri-Staple during Distal Pancreatectomy
RETTS-DP trial
Japan |
Patients who underwent distal pancreatectomy
Hepato-biliary-pancreatic surgery |
Others
NO
To investigate whetehr use of Reinforced Reload with Tri-Staple can significantly reduce the incidence of pancreatic fistula compared with Tri-Staple.
Efficacy
Exploratory
Incidence of Grade B/C postoperative pancreatic fistula within one month after surgery
Interventional
Parallel
Randomized
Individual
Single blind -participants are blinded
Active
YES
YES
Institution is considered as adjustment factor in dynamic allocation.
NO
Central registration
2
Treatment
Device,equipment |
Use of Reinforced Reload with Tri-Staple
Use of Tri-Staple
20 | years-old | <= |
Not applicable |
Male and Female
1.Patients who underwent distal pancreatectomy
2.Performance Status(PS)is 0-1 of Eastern Cooperative Oncology Group(ECOG)
3.more than 20 years old
4.Patients without distant metastasis excepting for liver metastasis from neouroendcrine tumor
5.Patients whose function of main organs is maintained.
6.Patients who canunderstand the contents of this clinical trial
1.patients with severe ischemic heart disease(NYHA > III)
2.patients with grade C of liver damage
3.patients requred countiuous oxygen administration due to severe lung disease
4.patients who received dialysis
5.patients with active cancer disease that may influence perioerative adverse events.
6.Patients who enable to enroll this trial due to their mental illness.
7.Patients who reject to enroll this trial
120
1st name | |
Middle name | |
Last name | Yoshiaki Murakami |
Hiroshima University Hospital
Gastrointestinal Surgery
1-2-3,KASUMI, MINAMI-KU, Hiroshima, JAPAN
082-257-5215
mura777@hiroshima-u.ac.jp
1st name | |
Middle name | |
Last name | Naru Kondo |
Hiroshima University Hospital
Gastrointestinal Surgery
1-2-3,KASUMI, MINAMI-KU, Hiroshima, JAPAN
082-257-5215
k-naru-surg@hiroshima-u.ac.jp
Hiroshima University Hospital
No
Other
NO
広島大学病院(広島県)
2016 | Year | 05 | Month | 18 | Day |
Published
Completed
2016 | Year | 05 | Month | 11 | Day |
2016 | Year | 05 | Month | 18 | Day |
2018 | Year | 01 | Month | 31 | Day |
2018 | Year | 02 | Month | 28 | Day |
2018 | Year | 04 | Month | 30 | Day |
2018 | Year | 11 | Month | 30 | Day |
2016 | Year | 05 | Month | 18 | Day |
2019 | Year | 02 | Month | 05 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025457